Annual report pursuant to Section 13 and 15(d)

Income Taxes - Components of deferred Tax Assets and Deferred Tax Liabilities (Detail)

v3.20.2
Income Taxes - Components of deferred Tax Assets and Deferred Tax Liabilities (Detail) - USD ($)
Jun. 30, 2020
Jun. 30, 2019
Deferred tax assets:    
Non-capital losses carried forward $ 11,870,922 $ 10,823,529
Capital losses carried forward 17,925 17,925
Financing costs 221,276  
Scientific research and development 604,489 534,398
Scientific research and development – Investment Tax Credits (“ITC”) 534,355 484,135
Deferred tax assets 13,248,967 11,859,987
Deferred tax liabilities:    
Scientific research and development – ITC (88,929) (81,386)
Gross future tax assets 13,160,038 11,778,601
Valuation allowance (13,160,038) (11,778,601)
Net future tax assets